Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1996
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742791A1 Macrocyclic difluorostatone derivatives useful as antiviral agents
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996EP0648122B1 PREVENTING TISSUE ADHESION USING $i(IN SITU) MODIFICATION OF ALGINATE
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136314A Isoxazoline compounds as antiinflammatory agents
11/20/1996CN1136313A Polyazacycloalkanes as dichelants
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/20/1996CN1136043A Human interleukin-6 inhibitor
11/20/1996CN1136039A |3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy¨-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/20/1996CN1033325C Preparation of antiinflammatory hydroxamic acids and N-hydroxyureas
11/20/1996CA2176654A1 Use of (.alpha.-aminomethyl-3,4-dichlorobenzyl)thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use
11/19/1996US5576444 Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
11/19/1996US5576437 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
11/19/1996US5576343 Aromatic amidine derivatives and salts thereof
11/19/1996US5576337 Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y
11/19/1996US5576333 Asthma treatment
11/19/1996US5576322 Anti-ischemic 2,4-diaminoquinazolines
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576320 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
11/19/1996US5576318 For treatment of central nervous system disorders
11/19/1996US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
11/19/1996US5576313 Enzyme inhibitors and anticarcinogenic agents
11/19/1996US5576293 Inhibitors of farnesyl-protein transferase
11/19/1996US5576287 Method for treating acute renal disease and failure
11/19/1996CA2176414A1 Acyl guanidine and amidine prodrugs
11/18/1996CA2176415A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/17/1996CA2176553A1 Fluorine-containing benzoylguanidines
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035788A2 Kunitz type protease inhibitors
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035715A2 Pcna binding substance
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035667A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
11/14/1996WO1996035447A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
11/14/1996WO1996035439A1 Low molecular yeast active substance extract and process for preparing the same
11/14/1996WO1996035433A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
11/14/1996WO1996035423A1 Antifungal composition
11/14/1996WO1996035419A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
11/14/1996WO1996028470A3 Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
11/14/1996WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996022068A3 Methods and pharmaceutical compositions employing desmethylselegiline
11/14/1996DE19517430A1 Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode The pharmaceutical dosage form of parathyroid hormone with a two- to six-hour drug release period
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2220497A1 Kunitz type protease inhibitors
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2218327A1 Pcna binding substance
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996CA2216877A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
11/13/1996EP0751778A4 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
11/13/1996EP0742228A1 IGF-1 superagonists
11/13/1996EP0742216A2 Cyclic amide derivatives
11/13/1996EP0742215A1 Cillianon, antibiotic from penicillin spe., and chemical derivatives thereof, method for their preparation and application
11/13/1996EP0742203A2 Vitamin D compounds and method of preparing these compounds
11/13/1996EP0742015A1 Prodrugs for beta-lactamase and uses thereof
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741743A1 Cyclic neurokinin a antagonists
11/13/1996EP0741741A1 Modified oligonucleotides
11/13/1996EP0741732A1 Process for the preparation of a salt of clavulanic acid
11/13/1996EP0741726A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/13/1996EP0741725A1 Indole derivatives as 5-ht 1? agonists
11/13/1996EP0741724A1 Neuroprotective chroman compounds
11/13/1996EP0741723A1 Triazole derivatives
11/13/1996EP0741722A1 Triazole derivatives
11/13/1996EP0741721A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
11/13/1996EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
11/13/1996EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/13/1996EP0741708A1 Cyanoguanidines as k-channel blockers
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741699A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741696A1 Malarial aspartic protease inhibitors
11/13/1996EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741686A1 New leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741571A1 Use of 2- 4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma
11/13/1996EP0683777B1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-[n-carboxamido]carboxamides as intiinflammatory agents
11/13/1996EP0678022B1 Application of riluzole as a radiorestorer
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/13/1996CN1135484A 3-alkylcarbonyl-thiadiazineone
11/13/1996CN1135480A Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574137 Recombinant gamma interferons having enhanced stability and methods therefor
1 ... 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 ... 1564